Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy, Ectopic | 7 | 2014 | 16 | 2.580 |
Why?
|
| Vacuum Curettage | 3 | 2014 | 3 | 1.080 |
Why?
|
| Cervix Uteri | 2 | 2014 | 64 | 0.950 |
Why?
|
| Balloon Occlusion | 2 | 2014 | 22 | 0.940 |
Why?
|
| Hysterectomy | 3 | 2009 | 64 | 0.810 |
Why?
|
| Pregnancy | 11 | 2014 | 2334 | 0.630 |
Why?
|
| Abortion, Therapeutic | 2 | 2013 | 5 | 0.560 |
Why?
|
| Cesarean Section | 2 | 2013 | 101 | 0.520 |
Why?
|
| Methotrexate | 2 | 2009 | 91 | 0.500 |
Why?
|
| Pregnancy, Tubal | 2 | 2009 | 5 | 0.500 |
Why?
|
| Fallopian Tubes | 2 | 2011 | 11 | 0.440 |
Why?
|
| Postmenopause | 2 | 2002 | 93 | 0.400 |
Why?
|
| Pregnancy, Abdominal | 1 | 2011 | 2 | 0.400 |
Why?
|
| Abdominal Pain | 2 | 2009 | 97 | 0.390 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2009 | 10 | 0.350 |
Why?
|
| Uterine Diseases | 1 | 2009 | 7 | 0.340 |
Why?
|
| Peritoneal Diseases | 1 | 2009 | 6 | 0.340 |
Why?
|
| Cecal Diseases | 1 | 2009 | 6 | 0.340 |
Why?
|
| Appendix | 1 | 2009 | 9 | 0.340 |
Why?
|
| Intussusception | 1 | 2009 | 16 | 0.330 |
Why?
|
| Ultrasonic Therapy | 1 | 2009 | 19 | 0.330 |
Why?
|
| Fistula | 1 | 2009 | 29 | 0.330 |
Why?
|
| Appendicitis | 1 | 2009 | 55 | 0.320 |
Why?
|
| Postoperative Complications | 2 | 2013 | 1615 | 0.310 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 286 | 0.270 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2002 | 38 | 0.260 |
Why?
|
| Female | 15 | 2014 | 38074 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2014 | 79 | 0.230 |
Why?
|
| Progestins | 1 | 2002 | 19 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 20 | 0.200 |
Why?
|
| Women's Health | 1 | 2002 | 148 | 0.200 |
Why?
|
| Hysteroscopy | 2 | 2013 | 3 | 0.190 |
Why?
|
| Ovary | 2 | 2011 | 99 | 0.180 |
Why?
|
| Adult | 8 | 2014 | 21403 | 0.170 |
Why?
|
| Humans | 15 | 2014 | 68618 | 0.170 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 77 | 0.160 |
Why?
|
| Hysterectomy, Vaginal | 1 | 1996 | 4 | 0.140 |
Why?
|
| Vagina | 1 | 1996 | 88 | 0.130 |
Why?
|
| Risk Factors | 4 | 2011 | 5731 | 0.120 |
Why?
|
| Laparoscopy | 1 | 1996 | 237 | 0.120 |
Why?
|
| Embryo Implantation | 1 | 2013 | 17 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 43 | 0.120 |
Why?
|
| Pregnancy Outcome | 2 | 2009 | 157 | 0.120 |
Why?
|
| Cicatrix | 1 | 2013 | 60 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2013 | 122 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2002 | 20 | 0.100 |
Why?
|
| Abdomen | 1 | 2011 | 80 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1140 | 0.100 |
Why?
|
| Estrogens | 2 | 2002 | 173 | 0.100 |
Why?
|
| Oligohydramnios | 1 | 2009 | 7 | 0.080 |
Why?
|
| Labor, Induced | 1 | 2009 | 18 | 0.080 |
Why?
|
| Surgical Instruments | 1 | 2009 | 44 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2009 | 56 | 0.080 |
Why?
|
| Postoperative Period | 1 | 2009 | 238 | 0.080 |
Why?
|
| Gestational Age | 1 | 2009 | 389 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2009 | 202 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2009 | 453 | 0.070 |
Why?
|
| Sterilization, Tubal | 1 | 2006 | 5 | 0.070 |
Why?
|
| Physicians' Offices | 1 | 2006 | 8 | 0.070 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 33 | 0.070 |
Why?
|
| Recurrence | 1 | 2009 | 948 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 1420 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2006 | 108 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2002 | 940 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2455 | 0.050 |
Why?
|
| Hot Flashes | 1 | 2002 | 8 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 31 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2002 | 16 | 0.050 |
Why?
|
| Progesterone | 1 | 2002 | 115 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7029 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2014 | 7277 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 186 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 69 | 0.050 |
Why?
|
| Rabbits | 1 | 2002 | 509 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 2223 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 425 | 0.040 |
Why?
|
| Decision Making | 1 | 2002 | 410 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2002 | 402 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 848 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 1998 | 21 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 4655 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 931 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 3259 | 0.040 |
Why?
|
| Genital Diseases, Female | 1 | 1996 | 23 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 1996 | 38 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2002 | 2007 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1996 | 169 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2002 | 2358 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 2279 | 0.030 |
Why?
|
| Education, Medical | 1 | 1996 | 147 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2002 | 3705 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 1536 | 0.030 |
Why?
|
| Neoplasms | 1 | 2002 | 1667 | 0.020 |
Why?
|
| Middle Aged | 2 | 2002 | 21147 | 0.020 |
Why?
|
| South Carolina | 1 | 1996 | 2752 | 0.020 |
Why?
|
| Male | 1 | 2009 | 37321 | 0.020 |
Why?
|
| Animals | 1 | 2002 | 20881 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.010 |
Why?
|